U.S. market Closed. Opens in 11 hours 44 minutes

NRBO | NeuroBo Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Revenue7.00KN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue7.00K28.00K72.00K67.00K17.00KN/AN/AN/AN/AN/A
Gross ProfitN/A-28.00K-72.00K-67.00K-17.00KN/AN/AN/AN/AN/A
Operating Expenses15.88M11.42M15.30M29.72M20.18M22.80M33.12M14.70MN/AN/A
Selling, General & Admin6.73M8.64M8.75M7.85M2.70M8.49MN/A5.96M3.18M214.00K
Research & Development9.15M2.78M6.55M21.87M17.48M14.31M22.69M8.74M3.99M52.00K
Other Operating Expenses7.00K-83.00KN/A-1.00K12.15M-178.00K10.44MN/AN/AN/A
Operating Income-15.89M-19.63M-15.30M-29.72M-20.18M-22.80M-33.12M-14.70M-7.17M-266.00K
Other Expenses / Income3.42M5.66M14.00K38.00K-1.14M-178.00K-291.00K110.00K-1.86M-54.00K
Before Tax Income-12.47M-13.97M-15.28M-29.68M-21.31M-23.64M-33.41M-14.59M-9.03M-320.00K
Income Tax ExpensesN/A-7.85M-62.00K-85.00K1.12M654.00KN/AN/AN/AN/A
Net Income-12.47M-6.12M-15.22M-29.59M-22.43M-23.64M-33.41M-14.59M-9.03M-320.00K
Interest ExpensesN/A2.19MN/A39.00K-22.00K654.00KN/AN/AN/AN/A
Basic Shares Outstanding5.07M321.70K96.43K67.57K21.77K141.71K13.80K232.36K172.20K212.07K
Diluted Shares Outstanding5.07M321.70K96.43K67.57K21.77K141.71K13.80K232.36K172.20K212.07K
EBITDA-15.88M-11.50M-15.30M-29.72M-19.06M-22.98M-33.41M-14.69M-6.07M-267.00K
EBITDA Margin-226,842.86%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-12.47M-11.78M-15.28M-29.64M-21.33M-22.33M-33.41M-14.59M-9.03M-320.00K
EBIT Margin-178,142.86%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙